Atlas Trials

Use of Intravenous Ferric Carboxymaltose in Treatment of Anemia in Cancer Patients Undergoing Chemotherapy

Clinical trial NCT04246021 · COMPLETED

Trial details

NCT number
NCT04246021
Sponsor
King Hussein Cancer Center
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
AnemiaCancer
Start date
2016-06-15
Primary completion
2017-12-31
Enrollment
84

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.